MY182773A - Method for indicating a presence or non-presence of aggressive prostate cancer - Google Patents
Method for indicating a presence or non-presence of aggressive prostate cancerInfo
- Publication number
- MY182773A MY182773A MYPI2015701578A MYPI2015701578A MY182773A MY 182773 A MY182773 A MY 182773A MY PI2015701578 A MYPI2015701578 A MY PI2015701578A MY PI2015701578 A MYPI2015701578 A MY PI2015701578A MY 182773 A MY182773 A MY 182773A
- Authority
- MY
- Malaysia
- Prior art keywords
- prostate cancer
- aggressive prostate
- indicating
- various forms
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G01N33/575—
-
- G01N33/57555—
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1251312 | 2012-11-20 | ||
| SE1350600 | 2013-05-16 | ||
| PCT/EP2013/074259 WO2014079865A1 (en) | 2012-11-20 | 2013-11-20 | Method for indicating a presence or non-presence of aggressive prostate cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY182773A true MY182773A (en) | 2021-02-05 |
Family
ID=49619938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2015701578A MY182773A (en) | 2012-11-20 | 2013-11-20 | Method for indicating a presence or non-presence of aggressive prostate cancer |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10431326B2 (enExample) |
| EP (2) | EP3327146A1 (enExample) |
| JP (2) | JP2016503301A (enExample) |
| KR (1) | KR20150110477A (enExample) |
| AU (1) | AU2013349801B2 (enExample) |
| BR (1) | BR112015011359B1 (enExample) |
| CA (2) | CA2891392C (enExample) |
| DK (1) | DK2922967T3 (enExample) |
| ES (1) | ES2667326T3 (enExample) |
| IL (1) | IL238724A0 (enExample) |
| MY (1) | MY182773A (enExample) |
| RU (1) | RU2675370C2 (enExample) |
| WO (1) | WO2014079865A1 (enExample) |
| ZA (1) | ZA201503460B (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3312749T3 (pl) | 2012-03-05 | 2024-10-07 | Oy Arctic Partners Ab | Metody i aparaty do prognozowania ryzyka raka gruczołu krokowego i objętości gruczołu krokowego |
| RU2669809C2 (ru) | 2012-11-20 | 2018-10-16 | Пхадиа Аб | Способ прогноза для индивидуумов с раком предстательной железы |
| CA2940445C (en) | 2014-03-11 | 2021-11-30 | Phadia Ab | Method for detecting a solid tumor cancer |
| US12326453B2 (en) | 2014-03-28 | 2025-06-10 | Opko Diagnostics, Llc | Compositions and methods for active surveillance of prostate cancer |
| PE20170298A1 (es) | 2014-03-28 | 2017-04-18 | Opko Diagnostics Llc | Composiciones y metodos relacionados con el diagnostico del cancer de prostata |
| JP6749337B2 (ja) | 2015-03-27 | 2020-09-02 | オプコ・ダイアグノスティクス・リミテッド・ライアビリティ・カンパニーＯｐｋｏ Ｄｉａｇｎｏｓｔｉｃｓ，Ｌｌｃ | 前立腺抗原標準およびその使用 |
| US9858665B2 (en) * | 2015-04-03 | 2018-01-02 | Regents Of The University Of Minnesota | Medical imaging device rendering predictive prostate cancer visualizations using quantitative multiparametric MRI models |
| HK1247824A1 (zh) * | 2015-04-29 | 2018-10-05 | 欧普科诊断有限责任公司 | 用於主动监控前列腺癌的组合物和方法 |
| WO2017164699A1 (ko) * | 2016-03-24 | 2017-09-28 | 서울대학교병원 (분사무소) | 전립선암과 관련된 단일염기다형성 및 이를 이용한 유전 위험도 점수의 개발 |
| ES2688213T3 (es) * | 2016-07-15 | 2018-10-31 | Proteomedix Ag | Método para detectar proteínas en muestras humanas y usos de dichos métodos |
| FI3577237T3 (fi) * | 2017-02-01 | 2023-08-29 | Phadia Ab | Menetelmä eturauhassyövän läsnäolon tai puuttumisen osoittamiseksi henkilöillä, joilla on tiettyjä ominaisuuksia |
| KR102093453B1 (ko) * | 2018-01-08 | 2020-03-25 | (주)인실리코젠 | 체형 및 대사 감수성 snp 마커 및 진단정보 제공방법 |
| WO2019144112A1 (en) | 2018-01-22 | 2019-07-25 | Phadia Ab | Method for the harmonization of assay results |
| IT201800021394A1 (it) * | 2018-12-28 | 2020-06-28 | Daniela Terracciano | Metodo in vitro per la diagnosi del cancro alla prostata |
| US11633146B2 (en) | 2019-01-04 | 2023-04-25 | Regents Of The University Of Minnesota | Automated co-registration of prostate MRI data |
| US11631171B2 (en) | 2019-01-10 | 2023-04-18 | Regents Of The University Of Minnesota | Automated detection and annotation of prostate cancer on histopathology slides |
| CN109628564B (zh) * | 2019-02-25 | 2022-02-01 | 北京市理化分析测试中心 | 一种用于检测snp多态性的引物组和利用引物组检测snp多态性的方法 |
| KR102371654B1 (ko) * | 2019-02-28 | 2022-03-08 | 주식회사 프로카젠 | 유전 변이의 개수에 따른 예측력을 고려한 전립선암 유전위험점수 산출장치, 산출방법 및 이의 기록매체 |
| KR102068667B1 (ko) * | 2019-02-28 | 2020-01-21 | 주식회사 프로카젠 | 전립선암 유전위험점수 산출장치, 산출방법 및 이의 기록매체 |
| KR102068666B1 (ko) * | 2019-02-28 | 2020-02-11 | 주식회사 프로카젠 | 인종 별 전립선암 유전위험점수 산출장치, 산출방법 및 이의 기록매체 |
| KR102371655B1 (ko) * | 2019-02-28 | 2022-03-08 | 주식회사 프로카젠 | 각 유전 변이 정보에 개별적인 가중치를 부여한 전립선암 유전위험점수 산출장치, 산출방법 및 이의 기록매체 |
| IT202000029948A1 (it) * | 2020-12-04 | 2022-06-04 | Nib Biotec S R L | Metodo per la diagnosi di tumore alla prostata in pazienti in differente fascia di età |
| JP7641532B2 (ja) * | 2020-08-28 | 2025-03-07 | 国立研究開発法人理化学研究所 | 前立腺がんの検査方法 |
| GB2599198B (en) * | 2021-06-15 | 2022-12-07 | A3P Biomedical Ab | A method for determining an appropriate time interval for further diagnostic testing for prostate cancer |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030219840A1 (en) | 2002-05-24 | 2003-11-27 | Mikolajczyk Stephen D. | Method of analyzing proenzyme forms of prostate specific antigen in serum to improve prostate cancer detection |
| FR2934698B1 (fr) | 2008-08-01 | 2011-11-18 | Commissariat Energie Atomique | Procede de prediction pour le pronostic ou le diagnostic ou la reponse therapeutique d'une maladie et notamment du cancer de la prostate et dispositif permettant la mise en oeuvre du procede. |
| CA2750062A1 (en) * | 2009-01-19 | 2010-07-22 | Katrin Stedronsky | Diagnostic assays for prostate cancer using psp94 and psa biomarkers |
| US20120121618A1 (en) | 2009-02-12 | 2012-05-17 | Dana-Farber Cancer Institute, Inc. | Predicting And Treating Prostate Cancer |
| EP2576835A4 (en) * | 2010-06-01 | 2013-10-30 | Univ Laval | PROGNOSTIC MARKERS FOR THE REPRODUCTION OF PROSTATE CANCER |
| US9732389B2 (en) | 2010-09-03 | 2017-08-15 | Wake Forest University Health Sciences | Methods and compositions for correlating genetic markers with prostate cancer risk |
| US20120202888A1 (en) | 2010-10-08 | 2012-08-09 | The Brigham And Women's Hospital, Inc. | Biomarkers of prostate cancer and predicting mortality |
| US20120150032A1 (en) * | 2010-12-13 | 2012-06-14 | Julius Gudmundsson | Sequence Variants Associated with Prostate Specific Antigen Levels |
| US20150094221A1 (en) | 2012-05-16 | 2015-04-02 | Phadia Ab | Method for Indicating the Presence or Non-Presence of Prostate Cancer |
| RU2669809C2 (ru) | 2012-11-20 | 2018-10-16 | Пхадиа Аб | Способ прогноза для индивидуумов с раком предстательной железы |
-
2013
- 2013-11-20 EP EP17210720.3A patent/EP3327146A1/en not_active Withdrawn
- 2013-11-20 WO PCT/EP2013/074259 patent/WO2014079865A1/en not_active Ceased
- 2013-11-20 MY MYPI2015701578A patent/MY182773A/en unknown
- 2013-11-20 BR BR112015011359-1A patent/BR112015011359B1/pt not_active IP Right Cessation
- 2013-11-20 CA CA2891392A patent/CA2891392C/en active Active
- 2013-11-20 CA CA3092807A patent/CA3092807C/en active Active
- 2013-11-20 AU AU2013349801A patent/AU2013349801B2/en active Active
- 2013-11-20 JP JP2015542308A patent/JP2016503301A/ja active Pending
- 2013-11-20 US US14/443,970 patent/US10431326B2/en active Active
- 2013-11-20 EP EP13792689.5A patent/EP2922967B1/en active Active
- 2013-11-20 KR KR1020157015113A patent/KR20150110477A/ko not_active Ceased
- 2013-11-20 ES ES13792689.5T patent/ES2667326T3/es active Active
- 2013-11-20 RU RU2015124054A patent/RU2675370C2/ru active
- 2013-11-20 DK DK13792689.5T patent/DK2922967T3/en active
-
2015
- 2015-05-10 IL IL238724A patent/IL238724A0/en unknown
- 2015-05-18 ZA ZA2015/03460A patent/ZA201503460B/en unknown
-
2018
- 2018-10-04 JP JP2018189147A patent/JP2019049559A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013349801B2 (en) | 2019-03-07 |
| ZA201503460B (en) | 2018-11-28 |
| CA2891392C (en) | 2020-11-03 |
| ES2667326T3 (es) | 2018-05-10 |
| RU2675370C2 (ru) | 2018-12-19 |
| DK2922967T3 (en) | 2018-04-16 |
| BR112015011359B1 (pt) | 2022-12-06 |
| JP2019049559A (ja) | 2019-03-28 |
| CA2891392A1 (en) | 2014-05-30 |
| CN105051206A (zh) | 2015-11-11 |
| CA3092807C (en) | 2024-02-27 |
| EP2922967A1 (en) | 2015-09-30 |
| KR20150110477A (ko) | 2015-10-02 |
| AU2013349801A1 (en) | 2015-05-28 |
| WO2014079865A1 (en) | 2014-05-30 |
| EP2922967B1 (en) | 2018-01-03 |
| JP2016503301A (ja) | 2016-02-04 |
| RU2015124054A (ru) | 2017-01-10 |
| US10431326B2 (en) | 2019-10-01 |
| HK1215594A1 (en) | 2016-09-02 |
| US20150317431A1 (en) | 2015-11-05 |
| BR112015011359A8 (pt) | 2019-10-01 |
| IL238724A0 (en) | 2015-06-30 |
| BR112015011359A2 (pt) | 2017-07-11 |
| EP3327146A1 (en) | 2018-05-30 |
| CA3092807A1 (en) | 2014-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY182773A (en) | Method for indicating a presence or non-presence of aggressive prostate cancer | |
| WO2013172779A3 (en) | Method for indicating the presence or non-presence of prostate cancer | |
| WO2013182912A3 (en) | Method for the diagnosis, prognosis and treatment of lung cancer metastasis | |
| HK1213946A1 (zh) | 用於使用c-maf对前列腺癌转移进行诊断、预後和治疗的方法 | |
| WO2012045905A3 (es) | Método para el diagnóstico, pronóstico y tratamiento de la metástasis de cáncer de mama | |
| WO2014140933A8 (en) | Method for the prognosis and treatment of cancer metastasis | |
| EA201590027A1 (ru) | Способы детекции заболеваний или состояний | |
| AU2013211850A8 (en) | Methods for profiling and quantitating cell-free RNA | |
| WO2015052583A3 (en) | Method for the prognosis and treatment of metastasizing cancer of the bone originating from breast cancer | |
| PH12017501841A1 (en) | Method for discriminating symptom of hepatic disease | |
| PH12018550037A1 (en) | Quencher containing water-soluble polymer-conjugated nanomaterial and use thereof | |
| IN2013CN01129A (enExample) | ||
| MY195999A (en) | Molecular Detection/Diagnosis Reagent for Tumor | |
| EP4604127A3 (en) | Methods and processes for non-invasive assessment of genetic variations | |
| MX347895B (es) | Dispositivo y método para obtener y procesar lecturas de medición de un ser vivo. | |
| EP3236262A3 (en) | Surrogate functional diagnostics test for cancer | |
| IN2012DN04944A (enExample) | ||
| WO2009083780A8 (en) | Breast cancer expression profiling | |
| EA201700123A1 (ru) | Способ прогнозирования варианта лекарственного препарата для лечения депрессии | |
| MY195045A (en) | Specific Biomarker Set For Non-Invasive Diagnosis of Liver Cancer | |
| EP2584045A4 (en) | METHOD FOR DETECTING COLORECTAL CANCER | |
| PH12015500388A1 (en) | Cancer diagnostic and therapeutic method targeting molecules expressed in cancer stem cells | |
| BR112015022977A2 (pt) | métodos para predição de risco de metástase em melanoma cutâneo | |
| UA116982C2 (uk) | Спосіб виявлення трансгенної кукурудзи dp-004114-3 | |
| MX2015015023A (es) | Metodo para la determinacion de cobre libre. |